Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Reprod Toxicol. 2019 Aug 12;90:8–14. doi: 10.1016/j.reprotox.2019.08.003

Table 3.

Adjusteda models of maternal perfluoroalkyl substance serum concentrations (ng/mL) and absolute gestational weight gain, stratified by pre-pregnancy BMI, in the Avon Longitudinal Study of Parents and Children sub-study population (N = 905).

Model Coefficientb 95% CI Hetero-
geneity
p-value
I2 statisticc
PFOA Underweight 0.06 −0.14, 0.26 0.32 0.0%
Normal weight −0.01 0.49 0.0%
Overweight −0.03 −0.33, 0.26 0.69 0.0%
Obese −0.29 −0.65, 0.08 0.40 0.0%
PFOS Underweight 0.02 −0.24, 0.28 0.78 0.0%
Normal weight −0.03 −0.13, 0.06 0.89 0.0%
Overweight −0.04 −0.29, 0.21 0.10 62.4%
Obese −0.07 −0.36, 0.22 0.29 12.1%
PFHxS Underweight 0.01 −0.12, 0.13 0.42 0.0%
Normal weight 0.01 −0.05, 0.07 0.34 0.0%
Overweight 0.11 −0.03, 0.25 0.96 0.0%
Obese 0.02 −0.15, 0.19 0.38 0.0%
PFNA Underweight 0.24 0.00, 0.48 0.80 0.0%
Normal weight 0.07 0.00, 0.15 0.04 76.0%
Overweight −0.07 −0.28, 0.13 0.17 48.1%
Obese −0.34 −0.99, 0.30 0.60 0.0%

Abbreviations: N, number; CI, confidence interval.

a

Adjusted for maternal education, prenatal smoking, maternal age at delivery, parity, pre-pregnancy BMI, gestational age at delivery, and gestational age at sample.

b

Coefficient representing a 10% increase in the PFAS of interest.

c

The I2 statistic indicates the percentage of variance in a meta-analysis that is attributable to study heterogeneity rather than chance. It is calculated using 100% × (Q − df)/Q where Q is the Cochran’s heterogeneity statistic, which is chi-square distributed [45].